- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeff White: Best Practices for Preventing Opioid Misuse
Jeff White, PharmD, MS, staff vice president, Anthem, outlines best practices for preventing opioid misuse.
Jeff White, PharmD, MS, staff vice president, Anthem, outlines best practices for preventing opioid misuse.
Transcript
What are some best practices for opioid management in order to prevent misuse?
Best practices include hard policies to help ensure clinically appropriate use. For example, 7-day supply limit for individuals newly starting on a short-acting opioid. Also, prior authorization for individuals newly starting on a long-acting opioid therapy. Also, medication assisted therapy, such as buprenorphine and naltrexone, should be made available, and also making available the rescue antidote called naloxone for those who are high risk for overdose.
Additional best practices include monitoring and understanding use patterns by prescribers and patients and developing and implementing programs that help guide clinically appropriate therapy.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
